BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3103670)

  • 1. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.
    Jørgensen M; Bonnevie-Nielsen V
    Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women.
    Häggroth L; Mattsson C; Felding P; Nilsson IM
    Thromb Res; 1986 Jun; 42(5):585-94. PubMed ID: 3087015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.
    Falkon L; Garí M; Borrell M; Fontcuberta J
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):33-8. PubMed ID: 1623118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
    Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
    Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C; Jie AF; Rijken DC; Verheijen JH
    Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.
    Masson C; Angles-Cano E
    Biochem J; 1988 Nov; 256(1):237-44. PubMed ID: 3146972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
    Colucci M; Paramo JA; Collen D
    J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA; Fernández Diaz FJ; Rocha E
    Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial clustering of defective release of t-PA.
    Petäjä J; Rasi V; Vahtera E; Myllylä G
    Br J Haematol; 1991 Oct; 79(2):291-5. PubMed ID: 1958488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA; Alfaro MJ; Rocha E
    Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Thorsen S; Philips M
    Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of tissue plasminogen activator and its "fast" inhibitor in plasma.
    Chmielewska J; Wiman B
    Clin Chem; 1986 Mar; 32(3):482-5. PubMed ID: 3081282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma.
    Takada Y; Takada A
    Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.
    Colucci M; Paramo JA; Collen D
    J Lab Clin Med; 1986 Jul; 108(1):53-9. PubMed ID: 3086473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture.
    Casslén B; Andersson A; Nilsson IM; Astedt B
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):419-24. PubMed ID: 3090554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasminogen activator inhibition levels in malignancy.
    de Jong E; Knot EA; Piket D; Iburg AH; Rijken DC; Veenhof KH; Dooijewaard G; ten Cate JW
    Thromb Haemost; 1987 Apr; 57(2):140-3. PubMed ID: 3110994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.